A Field study of household attack rates and the effectiveness of macrolide antibiotics in reducing household transmission of pertussis
DOI:
https://doi.org/10.33321/cdi.2015.39.4Keywords:
Bordetella pertussis, household transmission, secondary attack rates, antibiotics, waning immunityAbstract
Bordetella pertussis (whooping cough) is an endemic, highly contagious bacterial respiratory infection, which is notifiable to Australian state and territory health departments. Between 2008 and 2011 there was a substantial outbreak in New South Wales with an initial increase in cases occurring in North Coast New South Wales from late 2007. During September and October 2011 the North Coast Public Health Unit conducted a household study of secondary attack rates to assess the effectiveness of pertussis vaccination as well as the timely use of antibiotics in preventing household transmission. At the time the study was commenced, notified cases included a large proportion of individuals with a documented history of vaccination against pertussis. We found lower attack rates amongst vaccinated compared with non-vaccinated subjects in all age groups, with the exception of the 5–11 years age group, who were also primarily responsible for the introduction of pertussis into the household. There was an increased risk of pertussis transmission from the household first primary case to contacts when antibiotic treatment was commenced later than 7 days after the onset of symptoms compared with within 7 days. This protective effect of timely antibiotic treatment in relation to transmission highlights the need to control for antibiotic treatment in field studies of pertussis. The benefits of timely diagnosis and use of antibiotics in preventing household transmission underscore the importance of early presentation and diagnosis of pertussis cases, particularly in households with susceptible occupants. Commun Dis Intell 2015;39(1):E27–E33.
Downloads
References
Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. Canberra: Australian Government Department of Health and Ageing; 2013. [online] Accessed on 26 February 2014. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
Spokes PJ, Quinn HE, McAulty JM. Review of 2008–2009 pertussis epidemic in NSW: notifications and hospitalisations. N S W Public Health Bull 2010; 21(7–8):167–173.
NSW Department of Health. Pertussis control guideline – Pertussis response protocol for NSW Public Health Units. [online] Accessed on 18 April 2015. Available from: http://www.health.nsw.gov.au/Infectious/controlguideline/Pages/pertussis.aspx
Australian childhood immunisation register. Medicare. Australian Government Department of Human Services. [online] Accessed on 26 February 2014. Available from: http://www.medicareaustralia.gov.au/provider/patients/acir/
NSW immunisation schedule from 1 July 2013. NSW Health. [online] Accessed on 26 February 2014. Available from: http://www.health.nsw.gov.au/immunisation/Pages/schedule.aspx
Stata – StataCorp. 2005. Stata statistical software: release 9. College Station, TX: StataCorp LP.
Fine P, Clarkson J, Miller E, The efficacy of pertussis vaccines under conditions of household exposure further analysis of the 1978–80 PHLS/ERL study in 21 area health authorities in England. Int J Epidemiol 1988;17(3):635–642.
Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012;54(12):1730–1735.
Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, et al. California pertussis epidemic, 2010. J Pediatr 2012;161(6):1091–1096.
Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Eng J Med 2012;367(11):1012–1019.
Torvaldsen S, McIntyre P. Observational methods in epidemiological assessment of vaccine effectiveness. Commun Dis Intell 2002;26(3):451–457.
Orenstein W, Bernier R, Hinman A. Assessing vaccine efficacy in the field. Epidemiol Rev1988;10:212–240.
Sprauer MA, Cochi SL, Zell ER, Sutter RW, Mullen JR, Englender SJ, et al. Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Children 1992;146(2):177–181.
Steketee RW, Wassilak SGF, Adkins ND, Burstyn DG, Manclark CR, Berg J, et al. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988;157(3):434–440.
von König CH. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 2005;24(5 Suppl):S66–S68.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2015 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
